An update on actively targeted liposomes in advanced drug delivery to glioma
S Mojarad-Jabali, M Farshbaf, PR Walker… - International Journal of …, 2021 - Elsevier
High-grade glioma is one of the most aggressive types of cancer with a low survival rate
ranging from 12 to 15 months after the first diagnosis. Though being the most common …
ranging from 12 to 15 months after the first diagnosis. Though being the most common …
Recent advancements in liposome-targeting strategies for the treatment of gliomas: a systematic review
J Li, T Tan, L Zhao, M Liu, Y You, Y Zeng… - ACS Applied Bio …, 2020 - ACS Publications
Malignant tumors represent some of the most intractable diseases that endanger human
health. A glioma is a tumor of the central nervous system that is characterized by severe …
health. A glioma is a tumor of the central nervous system that is characterized by severe …
Liposome-based glioma targeted drug delivery enabled by stable peptide ligands
The treatment of glioma is one of the most challenging tasks in clinic. As an intracranial
tumor, glioma exhibits many distinctive characteristics from other tumors. In particular …
tumor, glioma exhibits many distinctive characteristics from other tumors. In particular …
Strategies for liposome drug delivery systems to improve tumor treatment efficacy
J Wang, J Gong, Z Wei - Aaps Pharmscitech, 2022 - Springer
In the advancement of tumor therapy, in addition to the search for new antitumor
compounds, the development of nano-drug delivery systems has opened up new pathways …
compounds, the development of nano-drug delivery systems has opened up new pathways …
Recent advances in liposome-based targeted cancer therapy
Nano-drug delivery systems have opened new pathways for tumor treatment by overcoming
some of the limitations of conventional drugs, such as physiological degradation, short half …
some of the limitations of conventional drugs, such as physiological degradation, short half …
Liposomes for tumor targeted therapy: a review
S Wang, Y Chen, J Guo, Q Huang - International journal of molecular …, 2023 - mdpi.com
Liposomes, the most widely studied nano-drug carriers in drug delivery, are sphere-shaped
vesicles consisting of one or more phospholipid bilayers. Compared with traditional drug …
vesicles consisting of one or more phospholipid bilayers. Compared with traditional drug …
Updates on the use of liposomes for active tumor targeting in cancer therapy
In the development of cancer chemotherapy, besides the discovery of new anticancer drugs,
a variety of nanocarrier systems for the delivery of previously developed and new …
a variety of nanocarrier systems for the delivery of previously developed and new …
Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review
Cancer is a broad term used to describe a group of diseases that have more than 270 types.
Today, due to the suffering of patients from the side effects of existing methods in the …
Today, due to the suffering of patients from the side effects of existing methods in the …
Liposomes for the treatment of brain cancer—A review
Due to their biocompatibility, non-toxicity, and surface-conjugation capabilities, liposomes
are effective nanocarriers that can encapsulate chemotherapeutic drugs and facilitate …
are effective nanocarriers that can encapsulate chemotherapeutic drugs and facilitate …
Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?
S Fathi, AK Oyelere - Future medicinal chemistry, 2016 - Taylor & Francis
Liposomes are biodegradable and biocompatible self-forming spherical lipid bilayer
vesicles. They can encapsulate and deliver one or more hydrophobic and hydrophilic …
vesicles. They can encapsulate and deliver one or more hydrophobic and hydrophilic …